Cala®, the bioelectronic medicine leader, today announced U.S. Food and Drug Administration (FDA) clearance of the Cala kIQ® Plus system, the next-generation of its wearable neurostimulation device ...
April is Parkinson's Disease Awareness Month, emphasizing early symptom recognition for timely diagnosis and improved patient ...
Cala announced today that it received FDA clearance for its kIQ Plus next-generation wearable neurostimulation device.
Combining medication with physical therapy in the early stages of Parkinson’s disease can significantly slow its progression, according to ...
PORCH Chattanooga, a local chapter of PORCH Communities, has teamed up with the International Student Leadership Council at UTC to plan a food drive after an urgent plea for donations to support ...
The acquisition helps diversify UCB’s small molecule-centric arsenal of seizure treatments with a potentially one-off therapy ...
Snake oil: a product that promises everything and delivers nothing. Are red light therapy and saunas in this class of ...
She talks and fights in her dreams, but doctor, we are tackling this spiritually.” Dr Nkechi Obianozie (PHOTO CREDIT: ...
The idea of getting a service dog had not crossed his mind until about two years ago. He was in Lancaster, Pennsylvania, at a U.S. Conference of Mayors conference when he had a Parkinson’s tremor, and ...
Hank is not EXACTLY an employee, but he’s proving his worth. The golden retriever lab mix has been working as a facility dog ...
Financing secures path to first NDA submission for buntanetap6-Month symptomatic data readout anticipated Q1 2027Alzheimer’s disease Phase 3 trial 75% enrolledParkinson's disease open-label study 28% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results